LONDON, March 13, 2026, 14:52 GMT
Reckitt Benckiser shares edged higher on Friday after the consumer-goods group disclosed a fresh 140,000-share buyback from March 12, the latest purchase under a £540 million third tranche launched this week. Cboe Europe estimates showed the stock at 5,325 pence by 14:42 GMT, up 0.17% on the day. 1
The timing matters. The repurchase lands days after Reckitt’s full-year results knocked more than 6% off the stock in its sharpest one-day fall in 11 months, as investors focused less on strong emerging-market sales than on hazy 2026 visibility for margins and EPS, or earnings per share. 2
A March 9 regulatory filing said Deutsche Bank will manage the new tranche, which is set to return up to £540 million by July 27. The bought-back shares will be held in treasury, meaning kept by the company rather than cancelled straight away; the first two tranches returned £250 million and £206 million. 3
Reckitt said on March 5 that Core Reckitt should deliver 4% to 5% like-for-like revenue growth in 2026, a measure that strips out currency swings and portfolio changes. It also warned on a weaker cold-and-flu season, a tough market in Europe and dilution to EPS from the Essential Home sale, even as its Fuel for Growth program is meant to offset “stranded costs” — overhead left behind after a disposal. 4
That mix is why the shares are still being picked over. “The margin benefit from the divestiture of essential home is being offset by stranded costs and FX,” Quilter Cheviot analyst Chris Beckett said after the results, referring to foreign-exchange effects. 2
Management’s bullish case still rests on emerging markets. Chief Executive Kris Licht said those regions were a “must-win” arena for the group after China and India helped drive 2025 core like-for-like revenue growth of 5.2%, ahead of Reckitt’s medium-term 4% to 5% range. 2
That puts Reckitt in familiar company. Like Unilever and Nestle, it has been pruning slower-growth assets and leaning harder into higher-margin brands, but disposals often expose leftover cost lines before savings catch up. 2
There is an obvious risk case. Europe may stay weak, price competition may stay heavy and the soft cold-and-flu season may give the group little help in the first quarter. Licht told analysts that “Europe will likely remain tough,” while CFO Shannon Eisenhardt said the size of any 2026 margin gain depends on “how much of those stranded costs we offset within 2026.” 5
Mead Johnson Nutrition is another loose end. Reckitt expects low-single-digit like-for-like growth there in 2026 after a mid-single-digit decline in the first quarter, and the group says it is still reviewing strategic options for the business. Friday’s small rise left the shares down 4.6% over five sessions. 4
